サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1127547

世界の動物用感染症治療薬市場：考察と予測 (2028年まで)

Global Veterinary Infectious Diseases Therapeutics Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 137 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の動物用感染症治療薬市場：考察と予測 (2028年まで)
出版日: 2022年09月22日
発行: QYResearch
ページ情報: 英文 137 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、動物用感染症治療薬 (Veterinary Infectious Diseases Therapeutics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 動物用感染症治療薬の製品概要
  • 市場：タイプ別
    • 世界の動物用感染症治療薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Antibiotics
    • Antiviral
    • Antifungal
    • Amebicides
    • Anthelmintics
  • 市場：アプリケーション別
    • 世界の動物用感染症治療薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Swine
    • Chicken
    • Dog
    • Cat
    • Cow
    • Horse
    • Other
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の動物用感染症治療薬の販売 推定および予測 2017-2028
  • 世界の動物用感染症治療薬の収益 推定および予測 2017-2028
  • 世界の動物用感染症治療薬の収益：地域別: 2017 VS 2021 VS 2028
  • 世界の動物用感染症治療薬の販売：地域別
    • 世界の動物用感染症治療薬の販売：地域別 (2017-2022)
    • 世界の販売 動物用感染症治療薬 ：地域別 (2023-2028)
  • 世界の動物用感染症治療薬の収益：地域別
    • 世界の動物用感染症治療薬の収益：地域別 (2017-2022)
    • 世界の動物用感染症治療薬の収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界の動物用感染症治療薬の販売：メーカー別
    • 世界の動物用感染症治療薬の上位メーカー：販売別 (2017-2022)
    • 世界の動物用感染症治療薬の販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： 動物用感染症治療薬2021
  • 世界の動物用感染症治療薬の収益：メーカー別
    • 世界の動物用感染症治療薬の収益：メーカー別 (2017-2022)
    • 世界の動物用感染症治療薬の収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： 動物用感染症治療薬の収益 2021
  • 世界の動物用感染症治療薬の販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界の動物用感染症治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界の動物用感染症治療薬のメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の動物用感染症治療薬の販売：タイプ別
    • 世界の動物用感染症治療薬の販売実績：タイプ別 (2017-2022)
    • 世界の動物用感染症治療薬の販売予測：タイプ別 (2023-2028)
    • 世界の動物用感染症治療薬の販売市場シェア：タイプ別 (2017-2028)
  • 世界の動物用感染症治療薬の収益：タイプ別
    • 世界の動物用感染症治療薬の収益実績：タイプ別 (2017-2022)
    • 世界の動物用感染症治療薬の収益予測：タイプ別 (2023-2028)
    • 世界の動物用感染症治療薬の収益市場シェア：タイプ別 (2017-2028)
  • 世界の動物用感染症治療薬の価格：タイプ別
    • 世界の動物用感染症治療薬の価格：タイプ別 (2017-2022)
    • 世界の動物用感染症治療薬の価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界の動物用感染症治療薬の販売：アプリケーション別
    • 世界の動物用感染症治療薬の販売実績：アプリケーション別 (2017-2022)
    • 世界の動物用感染症治療薬の販売予測：アプリケーション別 (2023-2028)
    • 世界の動物用感染症治療薬の販売市場シェア：アプリケーション別 (2017-2028)
  • 世界の動物用感染症治療薬の収益：アプリケーション別
    • 世界の動物用感染症治療薬の収益実績：アプリケーション別 (2017-2022)
    • 世界の動物用感染症治療薬の収益予測：アプリケーション別 (2023-2028)
    • 世界の動物用感染症治療薬の収益市場シェア：アプリケーション別 (2017-2028)
  • 世界の動物用感染症治療薬の価格：アプリケーション別
    • 世界の動物用感染症治療薬の価格：アプリケーション別 (2017-2022)
    • 世界の動物用感染症治療薬の価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の動物用感染症治療薬 市場規模：タイプ別
    • 北米の動物用感染症治療薬の販売：タイプ別 (2017-2028)
    • 北米の動物用感染症治療薬の収益：タイプ別 (2017-2028)
  • 北米の動物用感染症治療薬 市場規模：アプリケーション別
    • 北米の動物用感染症治療薬の販売：アプリケーション別 (2017-2028)
    • 北米の動物用感染症治療薬の収益：アプリケーション別 (2017-2028)
  • 北米の動物用感染症治療薬 市場規模：国別
    • 北米の動物用感染症治療薬の販売：国別 (2017-2028)
    • 北米の動物用感染症治療薬の収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の動物用感染症治療薬 市場規模：タイプ別
    • 欧州の動物用感染症治療薬の販売：タイプ別 (2017-2028)
    • 欧州の動物用感染症治療薬の収益：タイプ別 (2017-2028)
  • 欧州の動物用感染症治療薬 市場規模：アプリケーション別
    • 欧州の動物用感染症治療薬の販売：アプリケーション別 (2017-2028)
    • 欧州の動物用感染症治療薬の収益：アプリケーション別 (2017-2028)
  • 欧州の動物用感染症治療薬 市場規模：国別
    • 欧州の動物用感染症治療薬の販売：国別 (2017-2028)
    • 欧州の動物用感染症治療薬の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の動物用感染症治療薬 市場規模：タイプ別
    • アジア太平洋の動物用感染症治療薬の販売：タイプ別 (2017-2028)
    • アジア太平洋の動物用感染症治療薬の収益：タイプ別 (2017-2028)
  • アジア太平洋の動物用感染症治療薬 市場規模：アプリケーション別
    • アジア太平洋の動物用感染症治療薬の販売：アプリケーション別 (2017-2028)
    • アジア太平洋の動物用感染症治療薬の収益：アプリケーション別 (2017-2028)
  • アジア太平洋の動物用感染症治療薬 市場規模：地域別
    • アジア太平洋の動物用感染症治療薬の販売：地域別 (2017-2028)
    • アジア太平洋の動物用感染症治療薬の収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第9章 ラテンアメリカ

  • ラテンアメリカの動物用感染症治療薬 市場規模：タイプ別
    • ラテンアメリカの動物用感染症治療薬の販売：タイプ別 (2017-2028)
    • ラテンアメリカの動物用感染症治療薬の収益：タイプ別 (2017-2028)
  • ラテンアメリカの動物用感染症治療薬 市場規模：アプリケーション別
    • ラテンアメリカの動物用感染症治療薬の販売：アプリケーション別 (2017-2028)
    • ラテンアメリカの動物用感染症治療薬の収益：アプリケーション別 (2017-2028)
  • ラテンアメリカの動物用感染症治療薬 市場規模：国別
    • ラテンアメリカの動物用感染症治療薬の販売：国別 (2017-2028)
    • ラテンアメリカの動物用感染症治療薬の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカの動物用感染症治療薬 市場規模：タイプ別
    • 中東・アフリカの動物用感染症治療薬の販売：タイプ別 (2017-2028)
    • 中東・アフリカの動物用感染症治療薬の収益：タイプ別 (2017-2028)
  • 中東・アフリカの動物用感染症治療薬 市場規模：アプリケーション別
    • 中東・アフリカの動物用感染症治療薬の販売：アプリケーション別 (2017-2028)
    • 中東・アフリカの動物用感染症治療薬の収益：アプリケーション別 (2017-2028)
  • 中東・アフリカの動物用感染症治療薬 市場規模：国別
    • 中東・アフリカの動物用感染症治療薬の販売：国別 (2017-2028)
    • 中東・アフリカの動物用感染症治療薬の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Elanco Animal Health
  • Novartis Animal Health
  • Merck
  • Pfizer Animal Health
  • Sanofi
  • Boehringer Ingelheim Vetmedica
  • Dechra Animal Health
  • Ceva Sante Animale
  • Elanco Animal Health
  • Virbac

第12章 業界チェーンと販売チャネルの分析

  • 動物用感染症治療薬 業界チェーン分析
  • 動物用感染症治療薬 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 動物用感染症治療薬 生産形態とプロセス
  • 動物用感染症治療薬 販売およびマーケティング
    • 動物用感染症治療薬 販売チャネル
    • 動物用感染症治療薬 卸業者
  • 動物用感染症治療薬 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • 動物用感染症治療薬 業界動向
  • 動物用感染症治療薬 市場の促進要因
  • 動物用感染症治療薬 市場の課題
  • 動物用感染症治療薬 市場の抑制要因

第14章 世界の動物用感染症治療薬の主な市場調査結果

第15章 付録

図表
  • Table 1. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Antibiotics
  • Table 3. Major Manufacturers of Antiviral
  • Table 4. Major Manufacturers of Antifungal
  • Table 5. Major Manufacturers of Amebicides
  • Table 6. Major Manufacturers of Anthelmintics
  • Table 7. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 8. Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 9. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022) & (KG)
  • Table 10. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2017-2022)
  • Table 11. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2023-2028) & (KG)
  • Table 12. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2023-2028)
  • Table 13. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022) & (US$ Million)
  • Table 14. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2017-2022)
  • Table 15. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028) & (US$ Million)
  • Table 16. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2023-2028)
  • Table 17. Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2017-2022) & (KG)
  • Table 18. Global Veterinary Infectious Diseases Therapeutics Sales Share by Manufacturers (2017-2022)
  • Table 19. Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2017-2022)
  • Table 21. Veterinary Infectious Diseases Therapeutics Price by Manufacturers (2017-2022) &(USD/KG)
  • Table 22. Global Veterinary Infectious Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 23. Global Veterinary Infectious Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Infectious Diseases Therapeutics as of 2021)
  • Table 24. Veterinary Infectious Diseases Therapeutics Manufacturing Base Distribution and Headquarters
  • Table 25. Manufacturers Veterinary Infectious Diseases Therapeutics Product Offered
  • Table 26. Date of Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
  • Table 29. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
  • Table 30. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2017-2022)
  • Table 31. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2023-2028)
  • Table 32. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
  • Table 33. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
  • Table 34. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2017-2022)
  • Table 35. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2023-2028)
  • Table 36. Veterinary Infectious Diseases Therapeutics Price by Type (2017-2022) & (USD/KG)
  • Table 37. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2023-2028) & (USD/KG)
  • Table 38. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
  • Table 39. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
  • Table 40. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2017-2022)
  • Table 41. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2023-2028)
  • Table 42. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
  • Table 43. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
  • Table 44. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2017-2022)
  • Table 45. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2023-2028)
  • Table 46. Veterinary Infectious Diseases Therapeutics Price by Application (2017-2022) & (USD/KG)
  • Table 47. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2023-2028) & (USD/KG)
  • Table 48. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
  • Table 49. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
  • Table 50. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
  • Table 51. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
  • Table 52. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
  • Table 53. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
  • Table 54. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
  • Table 55. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
  • Table 56. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
  • Table 57. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
  • Table 58. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
  • Table 59. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
  • Table 60. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
  • Table 61. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
  • Table 62. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
  • Table 63. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
  • Table 64. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
  • Table 65. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
  • Table 66. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
  • Table 67. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
  • Table 68. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
  • Table 69. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
  • Table 70. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
  • Table 71. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
  • Table 72. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
  • Table 73. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
  • Table 74. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
  • Table 75. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
  • Table 76. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
  • Table 77. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
  • Table 78. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
  • Table 79. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
  • Table 80. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022) & (KG)
  • Table 81. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2023-2028) & (KG)
  • Table 82. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022) & (US$ Million)
  • Table 83. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028) & (US$ Million)
  • Table 84. Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
  • Table 85. Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
  • Table 86. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
  • Table 87. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
  • Table 88. Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
  • Table 89. Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
  • Table 90. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
  • Table 91. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
  • Table 92. Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
  • Table 93. Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
  • Table 94. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
  • Table 95. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
  • Table 96. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
  • Table 97. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
  • Table 98. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
  • Table 99. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
  • Table 100. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
  • Table 101. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
  • Table 102. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
  • Table 103. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
  • Table 104. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
  • Table 105. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
  • Table 106. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
  • Table 107. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
  • Table 108. Elanco Animal Health Corporation Information
  • Table 109. Elanco Animal Health Description and Major Businesses
  • Table 110. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 111. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 112. Elanco Animal Health Recent Developments
  • Table 113. Novartis Animal Health Corporation Information
  • Table 114. Novartis Animal Health Description and Major Businesses
  • Table 115. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 116. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 117. Novartis Animal Health Recent Developments
  • Table 118. Merck Corporation Information
  • Table 119. Merck Description and Major Businesses
  • Table 120. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 121. Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 122. Merck Recent Developments
  • Table 123. Pfizer Animal Health Corporation Information
  • Table 124. Pfizer Animal Health Description and Major Businesses
  • Table 125. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 126. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 127. Pfizer Animal Health Recent Developments
  • Table 128. Sanofi Corporation Information
  • Table 129. Sanofi Description and Major Businesses
  • Table 130. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 131. Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 132. Sanofi Recent Developments
  • Table 133. Boehringer Ingelheim Vetmedica Corporation Information
  • Table 134. Boehringer Ingelheim Vetmedica Description and Major Businesses
  • Table 135. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 136. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 137. Boehringer Ingelheim Vetmedica Recent Developments
  • Table 138. Dechra Animal Health Corporation Information
  • Table 139. Dechra Animal Health Description and Major Businesses
  • Table 140. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 141. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 142. Dechra Animal Health Recent Developments
  • Table 143. Ceva Sante Animale Corporation Information
  • Table 144. Ceva Sante Animale Description and Major Businesses
  • Table 145. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 146. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 147. Ceva Sante Animale Recent Developments
  • Table 148. Elanco Animal Health Corporation Information
  • Table 149. Elanco Animal Health Description and Major Businesses
  • Table 150. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 151. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 152. Elanco Animal Health Recent Developments
  • Table 153. Virbac Corporation Information
  • Table 154. Virbac Description and Major Businesses
  • Table 155. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
  • Table 156. Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 157. Virbac Recent Developments
  • Table 158. Key Raw Materials Lists
  • Table 159. Raw Materials Key Suppliers Lists
  • Table 160. Veterinary Infectious Diseases Therapeutics Distributors List
  • Table 161. Veterinary Infectious Diseases Therapeutics Customers List
  • Table 162. Veterinary Infectious Diseases Therapeutics Market Trends
  • Table 163. Veterinary Infectious Diseases Therapeutics Market Drivers
  • Table 164. Veterinary Infectious Diseases Therapeutics Market Challenges
  • Table 165. Veterinary Infectious Diseases Therapeutics Market Restraints
  • Table 166. Research Programs/Design for This Report
  • Table 167. Key Data Information from Secondary Sources
  • Table 168. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Veterinary Infectious Diseases Therapeutics Product Picture
  • Figure 3. Global Veterinary Infectious Diseases Therapeutics Market Share by Type in 2021 & 2028
  • Figure 3. Antibiotics Product Picture
  • Figure 4. Antiviral Product Picture
  • Figure 5. Antifungal Product Picture
  • Figure 6. Amebicides Product Picture
  • Figure 7. Anthelmintics Product Picture
  • Figure 8. Global Veterinary Infectious Diseases Therapeutics Market Share by Application in 2021 & 2028
  • Figure 9. Swine
  • Figure 10. Chicken
  • Figure 11. Dog
  • Figure 12. Cat
  • Figure 13. Cow
  • Figure 14. Horse
  • Figure 15. Other
  • Figure 16. Veterinary Infectious Diseases Therapeutics Report Years Considered
  • Figure 17. Global Veterinary Infectious Diseases Therapeutics Sales 2017-2028 (KG)
  • Figure 18. Global Veterinary Infectious Diseases Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 19. Global Veterinary Infectious Diseases Therapeutics Revenue 2017-2028 (US$ Million)
  • Figure 20. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 21. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2017-2022)
  • Figure 22. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2023-2028)
  • Figure 23. North America Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
  • Figure 24. North America Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
  • Figure 26. Europe Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
  • Figure 28. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
  • Figure 29. Latin America Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
  • Figure 30. Latin America Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
  • Figure 31. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
  • Figure 32. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
  • Figure 33. The Veterinary Infectious Diseases Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 34. The Top 5 and 10 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in the World: Market Share by Veterinary Infectious Diseases Therapeutics Revenue in 2021
  • Figure 35. Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 36. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
  • Figure 37. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
  • Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
  • Figure 39. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
  • Figure 40. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
  • Figure 41. North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
  • Figure 42. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
  • Figure 43. North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
  • Figure 44. North America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
  • Figure 45. North America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
  • Figure 46. U.S. Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 47. Canada Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 48. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
  • Figure 49. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
  • Figure 50. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
  • Figure 51. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
  • Figure 52. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
  • Figure 53. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
  • Figure 54. Germany Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 55. France Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 56. U.K. Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 57. Italy Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 58. Russia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 59. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
  • Figure 60. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
  • Figure 61. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
  • Figure 62. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
  • Figure 63. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Share by Region (2017-2028)
  • Figure 64. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Share by Region (2017-2028)
  • Figure 65. China Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 66. Japan Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 67. South Korea Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 68. India Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 69. Australia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 70. Taiwan Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 71. Indonesia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 72. Thailand Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 73. Malaysia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 74. Philippines Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 75. Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
  • Figure 76. Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
  • Figure 77. Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
  • Figure 78. Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
  • Figure 79. Latin America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
  • Figure 80. Latin America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
  • Figure 81. Mexico Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 82. Brazil Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 83. Argentina Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 84. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
  • Figure 85. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
  • Figure 86. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
  • Figure 87. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
  • Figure 88. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
  • Figure 89. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
  • Figure 90. Turkey Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 91. Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 92. U.A.E Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
  • Figure 93. Veterinary Infectious Diseases Therapeutics Value Chain
  • Figure 94. Veterinary Infectious Diseases Therapeutics Production Process
  • Figure 95. Channels of Distribution
  • Figure 96. Distributors Profiles
  • Figure 97. Bottom-up and Top-down Approaches for This Report
  • Figure 98. Data Triangulation
  • Figure 99. Key Executives Interviewed
目次

This research report focuses on the Veterinary Infectious Diseases Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Veterinary Infectious Diseases Therapeutics Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Antibiotics
    • 1.2.3 Antiviral
    • 1.2.4 Antifungal
    • 1.2.5 Amebicides
    • 1.2.6 Anthelmintics
  • 1.3 Market by Application
    • 1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Swine
    • 1.3.3 Chicken
    • 1.3.4 Dog
    • 1.3.5 Cat
    • 1.3.6 Cow
    • 1.3.7 Horse
    • 1.3.8 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Veterinary Infectious Diseases Therapeutics Sales by Region
    • 2.4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022)
    • 2.4.2 Global Sales Veterinary Infectious Diseases Therapeutics by Region (2023-2028)
  • 2.5 Global Veterinary Infectious Diseases Therapeutics Revenue by Region
    • 2.5.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022)
    • 2.5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
    • 3.1.1 Global Top Veterinary Infectious Diseases Therapeutics Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in 2021
  • 3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
    • 3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Veterinary Infectious Diseases Therapeutics Revenue in 2021
  • 3.3 Global Veterinary Infectious Diseases Therapeutics Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Veterinary Infectious Diseases Therapeutics Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type
    • 4.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Type (2017-2022)
    • 4.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
  • 4.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type
    • 4.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
  • 4.3 Global Veterinary Infectious Diseases Therapeutics Price by Type
    • 4.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Type (2017-2022)
    • 4.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application
    • 5.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Application (2017-2022)
    • 5.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
  • 5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application
    • 5.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
  • 5.3 Global Veterinary Infectious Diseases Therapeutics Price by Application
    • 5.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Application (2017-2022)
    • 5.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Veterinary Infectious Diseases Therapeutics Market Size by Type
    • 6.1.1 North America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
    • 6.1.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
  • 6.2 North America Veterinary Infectious Diseases Therapeutics Market Size by Application
    • 6.2.1 North America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
    • 6.2.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
  • 6.3 North America Veterinary Infectious Diseases Therapeutics Market Size by Country
    • 6.3.1 North America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
    • 6.3.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Veterinary Infectious Diseases Therapeutics Market Size by Type
    • 7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
    • 7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
  • 7.2 Europe Veterinary Infectious Diseases Therapeutics Market Size by Application
    • 7.2.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
    • 7.2.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
  • 7.3 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country
    • 7.3.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
    • 7.3.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Type
    • 8.1.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Application
    • 8.2.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Region
    • 8.3.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Type
    • 9.1.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
    • 9.1.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
  • 9.2 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Application
    • 9.2.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
    • 9.2.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
  • 9.3 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Country
    • 9.3.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
    • 9.3.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Type
    • 10.1.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Application
    • 10.2.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Country
    • 10.3.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Elanco Animal Health
    • 11.1.1 Elanco Animal Health Corporation Information
    • 11.1.2 Elanco Animal Health Overview
    • 11.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Elanco Animal Health Recent Developments
  • 11.2 Novartis Animal Health
    • 11.2.1 Novartis Animal Health Corporation Information
    • 11.2.2 Novartis Animal Health Overview
    • 11.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Novartis Animal Health Recent Developments
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Overview
    • 11.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Merck Recent Developments
  • 11.4 Pfizer Animal Health
    • 11.4.1 Pfizer Animal Health Corporation Information
    • 11.4.2 Pfizer Animal Health Overview
    • 11.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Pfizer Animal Health Recent Developments
  • 11.5 Sanofi
    • 11.5.1 Sanofi Corporation Information
    • 11.5.2 Sanofi Overview
    • 11.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Sanofi Recent Developments
  • 11.6 Boehringer Ingelheim Vetmedica
    • 11.6.1 Boehringer Ingelheim Vetmedica Corporation Information
    • 11.6.2 Boehringer Ingelheim Vetmedica Overview
    • 11.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Boehringer Ingelheim Vetmedica Recent Developments
  • 11.7 Dechra Animal Health
    • 11.7.1 Dechra Animal Health Corporation Information
    • 11.7.2 Dechra Animal Health Overview
    • 11.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Dechra Animal Health Recent Developments
  • 11.8 Ceva Sante Animale
    • 11.8.1 Ceva Sante Animale Corporation Information
    • 11.8.2 Ceva Sante Animale Overview
    • 11.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Ceva Sante Animale Recent Developments
  • 11.9 Elanco Animal Health
    • 11.9.1 Elanco Animal Health Corporation Information
    • 11.9.2 Elanco Animal Health Overview
    • 11.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Elanco Animal Health Recent Developments
  • 11.10 Virbac
    • 11.10.1 Virbac Corporation Information
    • 11.10.2 Virbac Overview
    • 11.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Virbac Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Veterinary Infectious Diseases Therapeutics Industry Chain Analysis
  • 12.2 Veterinary Infectious Diseases Therapeutics Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Veterinary Infectious Diseases Therapeutics Production Mode & Process
  • 12.4 Veterinary Infectious Diseases Therapeutics Sales and Marketing
    • 12.4.1 Veterinary Infectious Diseases Therapeutics Sales Channels
    • 12.4.2 Veterinary Infectious Diseases Therapeutics Distributors
  • 12.5 Veterinary Infectious Diseases Therapeutics Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Veterinary Infectious Diseases Therapeutics Industry Trends
  • 13.2 Veterinary Infectious Diseases Therapeutics Market Drivers
  • 13.3 Veterinary Infectious Diseases Therapeutics Market Challenges
  • 13.4 Veterinary Infectious Diseases Therapeutics Market Restraints

14 Key Findings in The Global Veterinary Infectious Diseases Therapeutics Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer